Enzo Biochem, Inc.
USD0.70
-0.00 (-0.16%)
CEO
Kara Cannon
IPO Date
1980-06-12
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
OTC
Country
US
Open
$0.69
Prev. Close
$0.70
Day Low
$0.69
Day High
$0.70
52W Low
$0.25
52W High
$1.19
Market Cap
$0.04B
Volume
0.15M
| 3.6 |
| 31 Jul 2022 | FY | 39.2% | -21.1% | -41.5% | -23.6% | 0.31 | 2.21 | -5.2 |
| 31 Jul 2021 | FY | 45.5% | 2.9% | 5.0% | 3.0% | 0.33 | 2.71 | 45.9 |
| 31 Jul 2020 | FY | 31.3% | -44.6% | -58.0% | -30.1% | 0.64 | 2.10 | -3.3 |
| 31 Jul 2019 | FY | 28.6% | -121.7% | -114.8% | -92.6% | 0.05 | 5.09 | -1.9 |
| 31 Jul 2018 | FY | 42.3% | -9.9% | -12.7% | -10.2% | 0.00 | 4.12 | -20.1 |
| 31 Jul 2017 | FY | 44.8% | -2.3% | -2.8% | -2.3% | 0.01 | 5.00 | -200.8 |
| 31 Jul 2016 | FY | 44.4% | 44.1% | 50.6% | 40.5% | 0.03 | 4.44 | 6.8 |
| 31 Jul 2015 | FY | 43.9% | -2.3% | -5.4% | -3.3% | 0.08 | 1.94 | -59.5 |
| -5.2 |
| 31 Oct 2024 | Q1 | 40.8% | -54.3% | -7.1% | -4.5% | 0.06 | 2.55 | -4.4 |
| 31 Jul 2024 | Q4 | 42.8% | -177.8% | -23.8% | -15.6% | 0.06 | 2.82 | -1.1 |
| 30 Apr 2024 | Q3 | 46.5% | -37.6% | -4.4% | -3.2% | 0.11 | 3.50 | -4.4 |
| 31 Jan 2024 | Q2 | 49.4% | -35.8% | -4.3% | -3.1% | 0.10 | 3.20 | -5.2 |
| 31 Oct 2023 | Q1 | 44.3% | -84.8% | -8.9% | -6.2% | 0.09 | 3.05 | -2.5 |
| 31 Jul 2023 | Q4 | 125.8% | -292.1% | 73.2% | 47.1% | 0.09 | 2.46 | 0.3 |
| 30 Apr 2023 | Q3 | 10.2% | -91.4% | -77.8% | -20.4% | 1.16 | 0.76 | -2.1 |
| 31 Jan 2023 | Q2 | 7.7% | -65.2% | -32.5% | -13.9% | 0.91 | 1.13 | -1.5 |